Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
- Resource Type
- Article
- Source
- In
eClinicalMedicine March 2023 57 - Subject
- Language
- ISSN
- 2589-5370